Supernus Pharmaceuticals SUPN Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $718.95M+8.6% | $661.82M+8.9% | $607.52M-8.9% | $667.24M+15.1% | ||
| $74.56M-4.3% | $77.91M-7.0% | $83.78M-3.9% | $87.22M+16.2% | ||
| $644.39M+10.4% | $583.91M+11.5% | $523.74M-9.7% | $580.02M+14.9% | ||
| 89.6%+1.4pp | 88.2%+2.0pp | 86.2%-0.7pp | 86.9%-0.1pp | ||
| $106.24M-2.4% | $108.8M+18.8% | $91.59M+22.9% | $74.55M-17.6% | ||
| $485.56M+51.0% | $321.58M-4.4% | $336.36M-10.8% | $377.22M+23.8% | ||
| $781.24M+34.7% | $580.15M-5.3% | $612.79M-1.3% | $621.11M+25.8% | ||
| -$62.28M-176% | $81.67M+1,650% | -$5.27M-111% | $46.12M-46.4% | ||
| -8.7%-21.0pp | 12.3%+13.2pp | -0.9%-7.8pp | 6.9%-7.9pp | ||
| $13.25M-18.2% | $16.2M+102% | $8.04M-45.0% | $14.62M+214% | ||
| -$49.03M-150% | $97.87M+3,434% | $2.77M-95.4% | $60.74M-17.0% | ||
| —— | $24.01M— | —— | $32K-99.8% | ||
| -$38.55M-152% | $73.87M+5,513% | $1.32M-97.8% | $60.71M+13.6% | ||
| -5.4%-16.5pp | 11.2%+10.9pp | 0.2%-8.9pp | 9.1%-0.1pp | ||
| -$0.68-152% | $1.32+7,609,281,930,405,189,000% | -$0.00-100% | $1.02+4.1% | ||
| $29.28M-81.9% | $162.08M+104% | $79.59M-39.6% | $131.67M+11.0% | ||
| 4.1%-20.4pp | 24.5%+11.4pp | 13.1%-6.6pp | 19.7%-0.7pp | ||
| -$62.28M-176% | $81.67M+1,650% | -$5.27M-111% | $46.12M-46.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Supernus Pharmaceuticals's revenue?
- Supernus Pharmaceuticals (SUPN) generated $776.8M in revenue over the trailing twelve months, up 16.3% year over year.
- Is Supernus Pharmaceuticals profitable?
- Supernus Pharmaceuticals is not currently profitable: it reported a net loss of $29.0M over the trailing twelve months, a -3.7% net margin.
- What are Supernus Pharmaceuticals's profit margins?
- Gross margin is 89.4% and operating margin is -7.8%, with a -3.7% net margin.
- What is Supernus Pharmaceuticals's earnings per share?
- Supernus Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.51.
- Where does Supernus Pharmaceuticals's income statement data come from?
- Every line is extracted from Supernus Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
